BRAF V600E Metastatic NSCLC
1 clinical trials · Condition
◉ Watch BRAF V600E Metastatic NSCLC
| Record | Firm | Date |
|---|---|---|
| Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors (NCT05003622) | Pierre Fabre Medicament | 2021-09-27 |
Track BRAF V600E Metastatic NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.